-
Je něco špatně v tomto záznamu ?
High-sensitivity 5-, 6-, and 7-color PNH WBC assays for both Canto II and Navios platforms
DR. Sutherland, F. Ortiz, G. Quest, A. Illingworth, M. Benko, R. Nayyar, I. Marinov,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2002
Medline Complete (EBSCOhost)
od 2012-03-01 do Před 1 rokem
Wiley Free Content
od 2003 do Před 1 rokem
PubMed
29381839
DOI
10.1002/cyto.b.21626
Knihovny.cz E-zdroje
- MeSH
- CD antigeny analýza MeSH
- imunofenotypizace přístrojové vybavení metody MeSH
- lidé MeSH
- paroxysmální hemoglobinurie diagnóza MeSH
- průtoková cytometrie přístrojové vybavení metody MeSH
- senzitivita a specificita MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare acquired hematopoietic stem cell disorder characterized by an inability to make Glyco-Phosphatidyl-Inositol (GPI)-linked cell surface structures. Fluorescent proaerolysin (FLAER-Alexa488) is increasingly used to detect GPI-deficient WBCs by flow cytometry. However, FLAER is not available in all countries and is expensive to obtain in others. An earlier study to compare FLAER-based and non-FLAER assays confirmed very good agreement between the two tubes suggesting a cost effective simultaneous evaluation of PNH neutrophils and monocytes is possible without FLAER. METHODS: We have used a single tube approach with a 7-color assay comprising FLAER-CD157-CD15-CD64-CD24-CD14-CD45. Conjugates were carefully selected and validated so that stained samples could be analyzed on either 10-color Navios or 8-color FACSCanto II platforms. The 6-color (minus CD14) and 5-color (minus CD24 and CD14) versions were also developed and compared with our predicate clinical lab 5-color assay comprising FLAER-CD157PE-CD64ECD-CD15PC5-CD45PC7. RESULTS/CONCLUSIONS: CD15-gated PNH neutrophil clone size was quantified using either FLAER and CD157, FLAER and CD24, or CD157 and CD24. CD64-gated PNH monocyte clone size was quantified using either FLAER and CD157, FLAER and CD14, or CD157 and CD14. Analysis of >40 PNH samples showed that the FLAER-based plots derive virtually identical data to the non-FLAER plot for neutrophils (R2 = 1) and monocytes (R2 = 0.9999) and that closely similar data can be acquired using both Canto II and Navios platforms with 7-, 6-, and 5-color versions of the assay. Assessment of non-PNH samples confirmed extremely low background rate of PNH phenotypes (neutrophils and monocytes) with all three approaches. © 2018 International Clinical Cytometry Society.
Cytoquest Corporation Toronto Ontario Canada
Dahl Chase Diagnostic Services Bangor Maine
EXBIO Praha a s Vestec Czech Republic
Institute of Hematology and Blood Transfusion Prague Czech Republic
Laboratory Medicine Program Toronto General Hospital Ontario Canada
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035425
- 003
- CZ-PrNML
- 005
- 20191014092828.0
- 007
- ta
- 008
- 191007s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/cyto.b.21626 $2 doi
- 035 __
- $a (PubMed)29381839
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Sutherland, D Robert $u Laboratory Medicine Program, Toronto General Hospital, Ontario, Canada.
- 245 10
- $a High-sensitivity 5-, 6-, and 7-color PNH WBC assays for both Canto II and Navios platforms / $c DR. Sutherland, F. Ortiz, G. Quest, A. Illingworth, M. Benko, R. Nayyar, I. Marinov,
- 520 9_
- $a BACKGROUND: Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare acquired hematopoietic stem cell disorder characterized by an inability to make Glyco-Phosphatidyl-Inositol (GPI)-linked cell surface structures. Fluorescent proaerolysin (FLAER-Alexa488) is increasingly used to detect GPI-deficient WBCs by flow cytometry. However, FLAER is not available in all countries and is expensive to obtain in others. An earlier study to compare FLAER-based and non-FLAER assays confirmed very good agreement between the two tubes suggesting a cost effective simultaneous evaluation of PNH neutrophils and monocytes is possible without FLAER. METHODS: We have used a single tube approach with a 7-color assay comprising FLAER-CD157-CD15-CD64-CD24-CD14-CD45. Conjugates were carefully selected and validated so that stained samples could be analyzed on either 10-color Navios or 8-color FACSCanto II platforms. The 6-color (minus CD14) and 5-color (minus CD24 and CD14) versions were also developed and compared with our predicate clinical lab 5-color assay comprising FLAER-CD157PE-CD64ECD-CD15PC5-CD45PC7. RESULTS/CONCLUSIONS: CD15-gated PNH neutrophil clone size was quantified using either FLAER and CD157, FLAER and CD24, or CD157 and CD24. CD64-gated PNH monocyte clone size was quantified using either FLAER and CD157, FLAER and CD14, or CD157 and CD14. Analysis of >40 PNH samples showed that the FLAER-based plots derive virtually identical data to the non-FLAER plot for neutrophils (R2 = 1) and monocytes (R2 = 0.9999) and that closely similar data can be acquired using both Canto II and Navios platforms with 7-, 6-, and 5-color versions of the assay. Assessment of non-PNH samples confirmed extremely low background rate of PNH phenotypes (neutrophils and monocytes) with all three approaches. © 2018 International Clinical Cytometry Society.
- 650 _2
- $a CD antigeny $x analýza $7 D015703
- 650 _2
- $a průtoková cytometrie $x přístrojové vybavení $x metody $7 D005434
- 650 _2
- $a paroxysmální hemoglobinurie $x diagnóza $7 D006457
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunofenotypizace $x přístrojové vybavení $x metody $7 D016130
- 650 _2
- $a senzitivita a specificita $7 D012680
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ortiz, Fernando $u Cytoquest Corporation, Toronto, Ontario, Canada.
- 700 1_
- $a Quest, Graeme $u Laboratory Medicine Program, Toronto General Hospital, Ontario, Canada.
- 700 1_
- $a Illingworth, Andrea $u Dahl-Chase Diagnostic Services, Bangor, Maine.
- 700 1_
- $a Benko, Miroslav $u EXBIO Praha, a.s. Vestec, Czech Republic.
- 700 1_
- $a Nayyar, Rakesh $u Cytoquest Corporation, Toronto, Ontario, Canada.
- 700 1_
- $a Marinov, Iuri $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 773 0_
- $w MED00013936 $t Cytometry. Part B, Clinical cytometry $x 1552-4957 $g Roč. 94, č. 4 (2018), s. 637-651
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29381839 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191014093252 $b ABA008
- 999 __
- $a ok $b bmc $g 1452085 $s 1073975
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 94 $c 4 $d 637-651 $e 20180305 $i 1552-4957 $m Cytometry. Part B, Clinical cytometry $n Cytometry B Clin Cytom $x MED00013936
- LZP __
- $a Pubmed-20191007